Cold chain packagers balance cost, performance and compliance approaches
When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.
Despite the buzz around digital media channels, pharma continues to pour marketing dollars into television
When state and federal governments are involved, prices and reimbursements have both regulatory and financial consequences
A contractual arrangement that could save time and money for brand owners
When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies
Recent regulatory actions and court cases highlight the importance of due diligence in reporting the value of service fees when federal reimbursements are concerned. The financial consequences can be substantial
Oncology is the market for today's pipeline products. Here's why the community setting needs to be preserved as a primary site of care to administer those products
Machine learning offers business knowledge based on the data that marketers and sales teams generate
IoT takes you from living in the past to shaping the future
Integrating pharma communications with electronic health-record systems brings value to patients and providers
International efforts to standardize guidelines for observational research could move the entire field forward
Sales Compensation Solutions, a new book from ZS Associates, outlines problems and solutions
By running Commercial Operations like a stand-alone business, executives can sharpen their focus on strategy, tactics and overall performance
When state and federal governments are involved, prices and reimbursements have both regulatory and financial consequences
International efforts to standardize guidelines for observational research could move the entire field forward
The importance of partners being flexible and optimizing their processes in today's virtual climate
Accreditation status is both an entry ticket and a competitive measure for specialty pharmacies to attract manufacturer attention
Like traditional thinking about key opinion leaders (KOLs) in healthcare, consider the DOL as part of a marketing campaign
In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'
In whatever form biosimilar legislation might take, patent holders will need to review their patent portfolios carefully
Well designed quality systems follow the product life cycle and foster a culture of quality
Top players from cold chain logistics’ pharma, biologics, and life sciences sector sound alarm on the upcoming burden on temperature-controlled shipping capacity as the global supply chain plans for the safe distribution of Covid-19 vaccines requiring strict temperature management, some as cold as -20 to -30⁰C.
Five steps to take when the duty for developing Risk Evaluation and Mitigation Strategies (REMS) is imposed on commercial operations